mdlinx mdlinx
Latest (291) Full Text Articles (9654) Focus on Diabetes Mellitus Article Summary

The Novel WHO 2010 Classification for Gastrointestinal Neuroendocrine Tumours Correlates Well with the Metastatic Potential of Rectal Neuroendocrine Tumours
Neuroendocrinology, 02/27/2012  Clinical Article

Jernman J et al. – The results show that rectal NETs classified as G1 according to the WHO 2010 classification have an indolent clinical course, whereas G2 NETs often metastasise. The WHO 2010 classification of NETs predicts the metastatic potential of rectal NETs better than the WHO 2000 classification.

Methods
  • The authors retrospectively classified 73 rectal NETs according to the novel WHO 2010 and the previous WHO 2000 classifications.
  • The aim was to assess the validity of the classifications in distinguishing indolent rectal NETs from metastasising tumours.

Results
  • Using the WHO 2010 criteria, they identified 61 G1 tumours, none of which had metastasised during follow-up.
  • Of 11 G2 tumours, 9 had shown distant metastases.
  • The only G3 neuroendocrine carcinoma that occurred had been disseminated at initial presentation.

► Click here to access PubMed, Publisher and related articles...

Your Unread Messages in Internal Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Internal Medicine Articles

Last month's top read Top Articles of 2012

Indexed Journals in Internal Medicine: New England Journal of Medicine, The Lancet, Archives of Internal Medicinemore

Other Topics in Internal Medicine

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close